Inventor
JOON BOK LEE
Inventor
US
Overview
Patents· 44 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Mprimary
A61MDevices for introducing media into, or onto, the body32%
G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data31%
A61BDiagnosis16%
A61KPreparations for medical, dental or toiletry purposes8%
H04LTransmission of digital information, e.g. telegraphic communication2%
A61FFilters implantable into blood vessels2%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations2%
G05BControl or regulating systems in general2%
G05DSystems for controlling or regulating non-electric variables2%
G06FElectric digital data processing2%
PatentTitleYear
12,592,306Devices and methods for initialization of drug delivery devices using measured analyte sensor information202612,569,619Techniques for determining automated insulin delivery dosages202612,564,679Adjusting medicament delivery parameters in an open loop medicament delivery mode202612,551,619Automated insulin delivery system using pramlintide202612,544,510Systems and methods for incorporating co-formulations of insulin in an automatic insulin delivery system202612,496,399Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk202512,495,994Meal bolus subcategories in model based insulin therapy202512,496,398Threshold based automatic glucose control response202512,491,316Scheduling of medicament bolus deliveries by a medicament delivery device at future dates and times with a computing device202512,433,998Activity mode for artificial pancreas system202512,427,251User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system202512,431,229Medicament delivery device with an adjustable and piecewise analyte level cost component to address persistent positive analyte level excursions202512,409,270Optimizing embedded formulations for drug delivery202512,406,760Exercise safety prediction based on physiological conditions202512,370,307Use of fuzzy logic in predicting user behavior affecting blood glucose concentration in a closed loop control system of an automated insulin delivery device202512,370,309Adaptive update of automatic insulin delivery (AID) control parameters202512,343,501Techniques to reduce risk of occlusions in drug delivery systems202512,300,375Early meal detection and calorie intake detection202512,257,420Initial total daily insulin setting for user onboarding202512,226,612Compensation for missing readings from a glucose monitor in an automated insulin delivery system202512,121,700Open-loop insulin delivery basal parameters based on insulin delivery records202412,121,701Systems and methods for incorporating co-formulations of insulin in an automatic insulin delivery system202412,102,796Model-based personalization scheme of an artificial pancreas for type I diabetes applications202412,090,301Safety constraints for a control algorithm based drug delivery system202412,036,389Prediction of meal and/or exercise events based on persistent residuals202411,986,630Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk202411,957,875Techniques and devices providing adaptivity and personalization in diabetes treatment202411,935,637Onboarding and total daily insulin adaptivity202411,911,596Initial total daily insulin setting for user onboarding202411,904,140Adaptable asymmetric medicament cost component in a control system for medicament delivery202411,883,632Safety constraints for a control algorithm based drug delivery system202411,833,329Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns202311,801,344Blood glucose rate of change modulation of meal and correction insulin bolus quantity202311,738,144Techniques enabling adaptation of parameters in aid systems by user input202311,684,716Techniques to reduce risk of occlusions in drug delivery systems202311,628,251Activity mode for artificial pancreas system202311,607,493Initial total daily insulin setting for user onboarding202311,565,043Safety constraints for a control algorithm based drug delivery system202311,565,039Event detection for drug delivery system202311,547,800User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system202311,551,802Early meal detection and calorie intake detection202311,439,754Optimizing embedded formulations for drug delivery202211,324,889Compensation for missing readings from a glucose monitor in an automated insulin delivery system202211,197,955Model-based personalization scheme of an artificial pancreas for type I diabetes applications2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2024Patents assigned to UNIV CALIFORNIA (2)· patent assignee history
2021–2026Based in US· patent location history
2022–2026Patents assigned to INSULET CORP (42)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| INSULET CORP | 42 | 2022–2026 |
| UNIV CALIFORNIA | 2 | 2021–2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 44 | 2021–2026 |